Which Medications Cannot Be Taken With Wegovy — and Which Interactions Need Closer Attention

Wegovy slows gastric emptying, which shifts the absorption timing of oral medicines taken alongside it, the interaction is pharmacokinetic, not always a direct drug-on-drug clash.
Oral contraceptives are a practical priority: UK guidance advises that women on tirzepatide (Mounjaro) add a backup method, but current evidence does not show the same absorption reduction for semaglutide, discuss your contraception with your prescriber regardless.
Medicines with narrow therapeutic windows (including warfarin, certain anticonvulsants and some thyroid drugs) may need closer monitoring when gastric emptying changes, even if a formal interaction is not listed for semaglutide specifically.
Wegovy is not recommended alongside other GLP-1 receptor agonists or other weight-loss medicines; it should not be combined with insulin without prescriber-supervised dose adjustment because of hypoglycaemia risk.

Certain medicines need extra thought when you start Wegovy. Wegovy (semaglutide) slows gastric emptying, which changes how quickly other medications are absorbed into your bloodstream. That effect can alter the timing and concentration of drugs you already take — sometimes in ways that matter clinically. As a prescription-only medicine, semaglutide is only available following assessment by a prescriber who reviews your full medication list before approving treatment. This page covers what the evidence and UK regulatory guidance actually say about medications that interact with Wegovy, and where the risks are most significant.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The medications that genuinely require caution alongside Wegovy, and why

The biggest misconception: it's not a list of banned drugs, it's a timing and monitoring issue

Most people searching this question expect a neat list of forbidden medications. The reality is more nuanced, and understanding it properly is more useful. Wegovy does not chemically block most drugs. What it does is slow the rate at which your stomach empties into the small intestine, which is where most oral medicines are absorbed. Slow that process and you shift the peak concentration of a drug, it may arrive later, in a lower or higher effective amount, than your prescriber originally planned for.

This matters most for medicines where the dose is calibrated carefully: anticoagulants like warfarin, some anticonvulsants such as lamotrigine, levothyroxine, and certain antihypertensives that depend on predictable absorption timing. None of these are necessarily incompatible with Wegovy, but anyone taking them should flag it at consultation so the prescriber can decide whether additional monitoring is sensible. The NHS patient information for semaglutide lists the categories where prescriber discussion is specifically recommended.

The simplest practical point: start your Wegovy pen at the same stage of your day as usual, keep your other medicines on their established schedule, and if you notice anything unexpected (a drug feeling less effective, or side effects that seem out of proportion) tell your prescriber rather than adjusting anything yourself.

The clearest real risks: insulin, other diabetes medicines, and weight-loss combinations

If you take insulin or a sulfonylurea (such as gliclazide or glibenclamide) for type 2 diabetes, the interaction with Wegovy is the most clinically established. Semaglutide reduces blood glucose on its own. Add it alongside insulin without adjusting the insulin dose and hypoglycaemia becomes a real possibility, blood sugar can fall too low, causing shakiness, sweating and confusion. This is not a reason to avoid Wegovy if you have diabetes, but it is a reason to have the conversation with your prescriber first and to follow any dose adjustment plan closely. You can read more about how semaglutide works in our full overview.

Combining Wegovy with other GLP-1 receptor agonists (for example, if someone is switching from a previous GLP-1 treatment and overlaps even briefly) is not recommended because the mechanism duplicates and the side-effect burden (particularly gastrointestinal) compounds. Two GLP-1 medicines at once are not two doses of benefit; they are a near-certain path to significant nausea, vomiting and potential dehydration. Similarly, combining Wegovy with other prescription or unlicensed weight-loss products is outside its licensed use and has no established safety data.

For a broader picture of how semaglutide interacts with other medicines across different drug classes, the semaglutide with other medications page goes into more detail.

Oral contraceptives, HRT, and the gastric-emptying question in practice

This is the area where patients most often have questions, and where it helps to be precise about which medicine we are talking about. For tirzepatide (Mounjaro), UK guidance recommends that women on the pill use a non-oral backup method for the first four weeks of treatment and for four weeks after each dose increase. The recommendation exists because tirzepatide's slowing of gastric emptying is pronounced enough to reduce pill absorption meaningfully.

The current picture for semaglutide is different. The NHS England guidance on weight-management injections does not list the same pill-absorption concern for semaglutide as it does for tirzepatide. That said, any prescriber seeing a patient on Wegovy medication and an oral contraceptive should acknowledge the theoretical mechanism and make an individual assessment. If you keep your pill in your gym bag and take it at a fixed time each morning, that established routine is worth mentioning at your consultation, consistency of timing reduces the variability gastric emptying might otherwise introduce.

For HRT, the picture is similarly individual. Transdermal HRT (patches and gels) bypasses the gut entirely, so the gastric-emptying effect of semaglutide is irrelevant to absorption. Oral HRT tablets follow the same principles as other oral medicines: it is not that they cannot be taken together, but timing and monitoring are worth discussing. The Wegovy drug interactions page covers these categories in detail.

Medicines to mention at your consultation, the practical checklist

Rather than framing this as prohibition, the most useful lens is disclosure. At any Wegovy consultation, mention that you take: any anticoagulant; any oral diabetes medicine or insulin; antiepileptic drugs; thyroid medication; immunosuppressants; any other weight-loss treatment; and any medicine your GP has said needs monitoring because of its narrow dosing range. The prescriber will consider whether the timing of your doses needs adjustment, whether any baseline test (such as an INR for warfarin users) should be arranged, and whether the combination is appropriate at all.

The MHRA's Yellow Card scheme exists precisely to capture unexpected drug interactions that emerge in real-world use, and our page on does Wegovy interact with other medications explains what patients and healthcare professionals can report anything that seems unusual. If after starting Wegovy a medicine you have taken for years starts behaving differently, that is worth reporting as well as discussing with your prescriber.

If you are already on Wegovy and have questions about a new medicine being added to your routine, our FAQs address common prescription queries, or you can reach our clinical team directly through our contact page. For those considering starting treatment, our guide to what medications you cannot take with semaglutide is a useful starting point alongside an honest, complete conversation about your current medications, which is exactly what the free consultation at nume's treatment page is designed to provide.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions